Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2002, p. 3981-3983, Vol. 46, No. 12
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.12.3981-3983.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Dipartimento di Scienze e Tecnologie Biomediche, Università di L'Aquila, I-67100, L'Aquila,1 Dipartimento di Scienze Morfologiche, Eidologiche e Cliniche, Sezione di Microbiologia, Università di Pavia, I-27100, Pavia,2 Ospedale di Circolo di Varese, I-21100, Varese,3 Dipartimento di Biologia Molecolare, Sezione di Microbiologia, Università di Siena, I-53100, Siena, Italy4
Received 15 May 2002/ Returned for modification 20 July 2002/ Accepted 27 August 2002
A blaTEM-92 gene was cloned from a Proteus mirabilis isolate and expressed in Escherichia coli. Production of the enzyme caused reduction of susceptibility to penicillins and narrow- to expanded-spectrum cephalosporins but not to moxalactam and cephamycins. Determination of kinetic parameters with the purified enzyme revealed hydrolysis of expanded-spectrum cephalosporins, while cephamycins, moxalactam, and aztreonam were very poorly or not hydrolyzed. Clavulanate and penicillanic acid sulfones acylated TEM-92 slowly, and deacylation occurred at measurable rates.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»